• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扫描?治愈?当然!

Scan? Cure? Sure!

机构信息

University of North CarolinaChapel Hill, USA.

出版信息

Oncologist. 2011;16(2):254-6. doi: 10.1634/theoncologist.2011-0014.

DOI:10.1634/theoncologist.2011-0014
PMID:21349952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3228087/
Abstract

A 61-year-old man undergoes a sigmoid colectomy for a T3N1 (two of 18 nodes) adenocarcinoma of the sigmoid colon. He recovers well and receives 6 months of adjuvant FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) uneventfully. At his first follow-up visit, the oncologist recommended every 3 month visits for a physical, liver function tests, and carcinoembryonic antigen (CEA) measurement; every 6 month chest, abdomen, and pelvic computed tomography (CT) scans for 3 years; and aspirin, vitamin D supplementation, and exercise. Is CT scanning appropriate in the follow-up of colon cancer patients? (This case was presented at Massachusetts General Hospital Cancer Center.).

摘要

一位 61 岁男性因乙状结肠癌 T3N1(18 个淋巴结中有 2 个转移)接受乙状结肠切除术。他恢复良好,并顺利接受了 6 个月的辅助 FOLFOX(氟尿嘧啶、亚叶酸钙和奥沙利铂)治疗。在首次随访时,肿瘤学家建议每 3 个月进行一次身体检查、肝功能检查和癌胚抗原(CEA)测量;前 3 年每 6 个月进行一次胸部、腹部和盆腔计算机断层扫描(CT);并建议服用阿司匹林、补充维生素 D 和进行运动。在结肠癌患者的随访中,CT 扫描是否合适?(本病例在马萨诸塞州综合医院癌症中心进行了介绍。)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a4/3228087/61b89c06ec92/onc9991107510002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a4/3228087/ead5cf270f27/onc9991107510001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a4/3228087/61b89c06ec92/onc9991107510002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a4/3228087/ead5cf270f27/onc9991107510001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a4/3228087/61b89c06ec92/onc9991107510002.jpg

相似文献

1
Scan? Cure? Sure!扫描?治愈?当然!
Oncologist. 2011;16(2):254-6. doi: 10.1634/theoncologist.2011-0014.
2
Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.根治性肝切除联合5-氟尿嘧啶/亚叶酸钙、奥沙利铂及贝伐单抗治疗升结肠癌伴肺和43处肝转移:病例报告
Int Surg. 2012 Jan-Mar;97(1):6-13. doi: 10.9738/CC88.1.
3
[A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].[1例晚期结肠癌经西妥昔单抗与奥沙利铂、亚叶酸钙和5-氟尿嘧啶联合治疗成功治愈]
Gan To Kagaku Ryoho. 2013 Nov;40(12):1962-4.
4
[A case of local recurrence of colon cancer responding to chemotherapy with low-dose oxaliplatin, 5-FU and l-LV].[一例对低剂量奥沙利铂、5-氟尿嘧啶和左亚叶酸钙化疗有反应的结肠癌局部复发病例]
Gan To Kagaku Ryoho. 2007 Aug;34(8):1291-3.
5
[COMPLETE RESECTION OF URACHAL CARCINOMA WITH SIGMOID COLON INVASION AFTER FOLFOX CHEMOTHERAPY: A CASE REPORT].[氟尿嘧啶、亚叶酸钙和奥沙利铂(FOLFOX)化疗后乙状结肠受侵脐尿管癌的根治性切除:1例报告]
Nihon Hinyokika Gakkai Zasshi. 2018;109(1):35-39. doi: 10.5980/jpnjurol.109.35.
6
Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.夹心式肝切除术联合分子靶向药物西妥昔单抗和贝伐珠单抗治疗结肠癌肝转移:1 例报告。
World J Surg Oncol. 2012 Jun 29;10:129. doi: 10.1186/1477-7819-10-129.
7
[A case of metastatic colon cancer to paraaortic lymph nodes and liver treated successfully with oxaliplatin combination chemotherapy].[1例经奥沙利铂联合化疗成功治疗的主动脉旁淋巴结及肝转移结肠癌]
Gan To Kagaku Ryoho. 2007 Jul;34(7):1135-7.
8
Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.血清血管内皮生长因子、碱性成纤维细胞生长因子及一氧化氮在结直肠癌患者中的预后作用
Cytokine. 2002 Nov 24;20(4):184-90. doi: 10.1006/cyto.2002.1993.
9
Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.贝伐珠单抗联合 FOLFOX 方案治疗结直肠腺癌肝转移
Anticancer Drugs. 2011 Jun;22 Suppl 2:S1-7. doi: 10.1097/01.cad.0000398726.60837.27.
10
Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.预后因素及辅助化疗在 Dukes B 期和 C 期结肠癌根治术后的作用及生存结局:马来西亚的经验
Asian Pac J Cancer Prev. 2015;16(6):2237-43. doi: 10.7314/apjcp.2015.16.6.2237.

本文引用的文献

1
Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases.结直肠癌肝转移根治性治疗后肿瘤数量与预后的系统评价
Br J Surg. 2009 Oct;96(10):1101-13. doi: 10.1002/bjs.6735.
2
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.在MOSAIC试验中,奥沙利铂、氟尿嘧啶和亚叶酸作为II期或III期结肠癌辅助治疗可提高总生存率。
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
3
Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults.
成人CT检查的重复扫描、累积辐射暴露及相关辐射诱发癌症风险
Radiology. 2009 Apr;251(1):175-84. doi: 10.1148/radiol.2511081296.
4
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.循环肿瘤细胞在转移性结直肠癌患者中的预后意义
Ann Oncol. 2009 Jul;20(7):1223-9. doi: 10.1093/annonc/mdn786. Epub 2009 Mar 12.
5
Follow-up strategies for patients treated for non-metastatic colorectal cancer.非转移性结直肠癌患者的随访策略
Cochrane Database Syst Rev. 2007 Jan 24(1):CD002200. doi: 10.1002/14651858.CD002200.pub2.
6
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.结直肠癌监测:美国临床肿瘤学会实践指南2005年更新版
J Clin Oncol. 2005 Nov 20;23(33):8512-9. doi: 10.1200/JCO.2005.04.0063. Epub 2005 Oct 31.
7
Prevention of radiocontrast nephropathy: back to basics.
JAMA. 2004 May 19;291(19):2376-7. doi: 10.1001/jama.291.19.2376.
8
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.常规血清癌胚抗原检测及计算机断层扫描在结直肠癌辅助化疗后患者监测中的价值
J Clin Oncol. 2004 Apr 15;22(8):1420-9. doi: 10.1200/JCO.2004.05.041. Epub 2004 Mar 8.
9
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.根治性切除结直肠癌患者的随访:实践指南
BMC Cancer. 2003 Oct 6;3:26. doi: 10.1186/1471-2407-3-26.
10
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.结直肠癌根治性切除术后强化随访对生存的影响:随机试验的系统评价和荟萃分析
BMJ. 2002 Apr 6;324(7341):813. doi: 10.1136/bmj.324.7341.813.